IPO Issue Details
Issue Price / Price Band₹85 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size22,96,000 shares (aggregating up to ₹19.52 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenFri, 29 Sep 2017
Subscription CloseWed, 04 Oct 2017
Anchor AllotmentThu, 28 Sep 2017
Basis of AllotmentTue, 10 Oct 2017
Initiation of RefundsWed, 11 Oct 2017
Credit of Shares to DematWed, 11 Oct 2017
Listing DateThu, 12 Oct 2017
UPI Mandate Deadline2017-10-04
Application & Investment Details
Retail — Min (1 Lots)₹1,36,000 — 1,600 shares
Retail — Max (13 Lots)₹1,768,000 (13 Lots)
HNI — Min (2 Lots)₹2,72,000 — 3,200 shares
Net Offer to Public21,66,400 shares (aggregating up to ₹18.41 Cr)
Reserved for Market Maker1,29,600 shares (aggregating up to ₹1.10 Cr)
Pre-IPO Promoter Holding63,35,500
Post-IPO Promoter Holding86,49,500
About Beta Drugs
Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.Beta Drugs Limited is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.Company Strengths:1. Focus on oncology segment. Manufacture over 50 products in this segment.2. 18 product registrations in various countries. Company is in-process of making additional 12 applications for product registration in various countries.
Objects of the Issue
Beta Drugs proposes to utilise the net proceeds from the Issue for the following objects:
1
Market Maker Shares Offered
1,29,600 (5.64%)
2
NII (HNI) Shares Offered
10,83,200 (47.18%)
3
Retail Shares Offered
10,83,200 (47.18%)
4
Total Shares Offered
22,96,000 (100.00%)
Shareholding & Lock-in
Pre-IPO Promoter Holding
63,35,500
Post-IPO Promoter Holding
86,49,500